226 related articles for article (PubMed ID: 24382124)
1. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
Shah VN; Shah CS; Bhadada SK; Rao DS
Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis.
Song A; Zhao H; Yang Y; Liu S; Nie M; Wang O; Xing X
J Endocrinol Invest; 2021 Aug; 44(8):1667-1677. PubMed ID: 33453021
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.
Grey A; Lucas J; Horne A; Gamble G; Davidson JS; Reid IR
J Clin Endocrinol Metab; 2005 Apr; 90(4):2122-6. PubMed ID: 15644400
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapy.
Mikhail N
South Med J; 2011 Jan; 104(1):29-33. PubMed ID: 21079532
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D status in primary hyperparathyroidism.
Saliba W; Lavi I; Rennert HS; Rennert G
Eur J Intern Med; 2012 Jan; 23(1):88-92. PubMed ID: 22153538
[TBL] [Abstract][Full Text] [Related]
8. Seasonal Variability in Vitamin D Levels No Longer Detectable in Primary Hyperparathyroidism.
Cong E; Walker MD; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3452-9. PubMed ID: 26120793
[TBL] [Abstract][Full Text] [Related]
9. Urinary calcium excretion in primary hyperparathyroidism: relationship to 25-hydroxyvitamin d status.
Bussey AD; Bruder JM
Endocr Pract; 2005; 11(1):37-42. PubMed ID: 16033734
[TBL] [Abstract][Full Text] [Related]
10. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
[TBL] [Abstract][Full Text] [Related]
11. Low vitamin D levels have become less common in primary hyperparathyroidism.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
[TBL] [Abstract][Full Text] [Related]
13. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin D replacement in primary hyperparathyroidism with concurrent vitamin D deficiency: a systematic review and meta-analysis.
Loh HH; Lim LL; Yee A; Loh HS; Vethakkan SR
Minerva Endocrinol; 2019 Jun; 44(2):221-231. PubMed ID: 28294593
[TBL] [Abstract][Full Text] [Related]
15. 1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism Apa1 influence bone mineral density in primary hyperparathyroidism.
Christensen MH; Apalset EM; Nordbø Y; Varhaug JE; Mellgren G; Lien EA
PLoS One; 2013; 8(2):e56019. PubMed ID: 23418495
[TBL] [Abstract][Full Text] [Related]
16. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.
Viccica G; Cetani F; Vignali E; Miccoli M; Marcocci C
Endocrine; 2017 Jan; 55(1):256-265. PubMed ID: 27033542
[TBL] [Abstract][Full Text] [Related]
17. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.
Boudou P; Ibrahim F; Cormier C; Sarfati E; Souberbielle JC
J Endocrinol Invest; 2006 Jun; 29(6):511-5. PubMed ID: 16840828
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D-binding protein levels in female patients with primary hyperparathyroidism.
Wang X; Shapses SA; Wei S; Sukumar D; Ghosh J
Endocr Pract; 2013; 19(4):609-13. PubMed ID: 23425651
[TBL] [Abstract][Full Text] [Related]
20. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
Farahnak P; Lärfars G; Sten-Linder M; Nilsson IL
J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
